Position in GILD
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$431,577
-$179,281 QoQ
Shares Held
3,416
-22.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.20%
of 13F equity value
Holder Rank
#1,451
of 2,266 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VICUS CAPITAL holds $5,105,271 across 9 Drug Manufacturers - General names. GILD ranks #5 (8.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
4,876 | $1,238,357 | |
| 2 | ABBV |
AbbVie Inc.
|
3,138 | $789,646 | |
| 3 | MRK |
Merck & Co., Inc.
|
5,836 | $749,926 | |
| 4 | LLY |
ELI LILLY & Co
|
584 | $700,467 | |
| 5 | GILD |
Gilead Sciences, Inc.
This page
|
3,416 | $431,577 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
6,303 | $363,178 | |
| 7 | NVS |
Novartis AG
|
2,251 | $352,776 | |
| 8 | AMGN |
Amgen Inc
|
716 | $259,277 |
All Filings in GILD
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $431,577 | 3,416 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $610,858 | 4,383 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $456,592 | 3,720 | Shares | Sole | 2026-01-22 | |
| 2025-09-30 | $420,246 | 3,786 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $413,988 | 3,734 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $493,580 | 4,405 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $399,223 | 4,322 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $366,800 | 4,375 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $398,349 | 5,806 | Shares | Sole | 2024-07-23 | |
| 2024-03-31 | $462,280 | 6,311 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $390,549 | 4,821 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $436,750 | 5,828 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $393,673 | 5,108 | Shares | Sole | 2023-08-17 | |
| 2023-03-31 | $307,984 | 3,712 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $343,142 | 3,997 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $258,419 | 4,189 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $229,253 | 3,709 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $206,767 | 3,478 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $233,078 | 3,210 | Shares | Sole | 2022-02-10 | |
| 2021-06-30 | $223,932 | 3,252 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $232,021 | 3,590 | Shares | Sole | 2021-05-04 | |
| 2020-09-30 | $304,512 | 4,819 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $513,728 | 6,677 | Shares | Sole | 2020-08-03 | |
| 2020-03-31 | $424,188 | 5,674 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||